What is the Skybiotech Healthcare Ltd share price today?

The share price of BSE:SKYBIOTECH-X on 01 Oct 2026 (as of 15:06:52 IST) is ₹116.2.

What is the BSE:SKYBIOTECH-X 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:SKYBIOTECH-X 52 week high low range shows a high of ₹220 and a low of ₹113.9.

What is the Skybiotech Healthcare Ltd market cap?

As on 01 Oct 2026, Skybiotech Healthcare Ltd market cap is ₹222523000.

What is the shareholding pattern of Skybiotech Healthcare Ltd Stock?

The shareholding pattern of Skybiotech Healthcare Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 63.48% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 36.52% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Skybiotech Healthcare Ltd?

The Price-to-Earnings (PE) ratio of Skybiotech Healthcare Ltd is 0, and the Price-to-Book (PB) ratio is 3.4859, as on 01 Oct 2026.

Skybiotech Healthcare Share Price

118.15+1.15 (+0.98%)

-40.87% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.98%

1 Week

+0.98%

1 Month

-2.19%

3 Month

-17.95%

6 Month

-14.94%

YTD

-32.52%

1 Year

-40.87%

5 Year

+281.13%

10 Year

Max

+281.74%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

117.00

113.90

High

118.15

125.00

176.40

210.00

218.20

About

Kapil Cotex Ltd. manufactures yarn linen and fabrics. The company manufactures grey knitted fabric for domestic and industrial use. The company was incorporated in 1983 and is based in Mumbai Read more

Textile

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

PAGEIND-ANSE

KPRMILL-ANSE

WELSPUNLIV-ANSE

VTL-ANSE

ARVIND-ANSE

MANYAVAR-ANSE

PGIL-ANSE

ICIL-ANSE

SWANCORP-ANSE

GARFIBRES-ANSE

SKYBIOTECH-XNSE

LTP

1W Low

1W High

Market cap (₹)

36760-761.05 (-2.03%)

36451.95

37575

40,927Cr

1082.4-18.5 (-1.68%)

1027

1105.85

36,043Cr

226.65-9.2 (-3.90%)

220.40

236.65

21,092Cr

528.8-7.65 (-1.43%)

522.30

540.40

15,297Cr

512.65-17.1 (-3.23%)

500

528

13,851Cr

492-8.45 (-1.69%)

484.35

510

12,188Cr

1322.2+48.45 (3.80%)

1262.55

1343.40

11,826Cr

454.2-16.85 (-3.58%)

433.75

469.45

8,645Cr

267-4.8 (-1.77%)

254.60

276.20

8,180Cr

761-11.8 (-1.53%)

750.70

787.65

7,471Cr

118.15+1.95 (1.68%)

117

118.15

22Cr

Skybiotech Healthcare Share Price

118.15+1.15 (+0.98%)

-40.87% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year0%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year0%

Stock Price CAGR

10 years-

5 years31%

3 years3%

1 year-41%

Return on Equity

10 years-26%

5 years-26%

3 years-26%

Last year-26%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	0%
-	-	-	0%
-	31%	3%	-41%
-26%	-26%	-26%	-26%

Peer Comparison

Symbol

PAGEIND-A

KPRMILL-A

WELSPUNLIV-A

VTL-A

ARVIND-A

MANYAVAR-A

PGIL-A

ICIL-A

SWANCORP-A

GARFIBRES-A

SKYBIOTECH-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
36,760	₹40927 Cr	54.15	172.86	775.02	₹764 Cr
1,082.4	₹36043 Cr	39.51	7.56	33.09	₹867 Cr
226.65	₹21092 Cr	75.97	1.7	7.24	₹204 Cr
528.8	₹15297 Cr	18.04	10.7	45.91	₹745 Cr
512.65	₹13851 Cr	33.44	2.04	26.78	₹414 Cr
492	₹12188 Cr	31.58	3.32	22.96	₹376 Cr
1,322.2	₹11826 Cr	38.11	10.88	43.68	₹278 Cr
454.2	₹8645 Cr	57.3	3.19	16.03	₹127 Cr
267	₹8180 Cr	36.58	-1	11.1	₹274 Cr
761	₹7471 Cr	35.56	6.62	25.24	₹199 Cr
118.15	₹22 Cr	—	-3	-6.31	-₹1 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024
₹49 L	₹2 Cr	₹96 L	₹2 Cr	₹2 Cr	₹1 Cr	₹3 Cr	₹2 Cr	₹0	₹0
₹6 L	₹15 L	₹8 L	₹4 L	₹4 L	-₹18 L	₹15 L	₹4 L	₹35 L	₹60 L
₹55 L	₹2 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹84 L	₹3 Cr	₹2 Cr	₹35 L	₹60 L
₹1 Cr	₹3 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹2 Cr	₹4 L	₹2 L
-₹46 L	-₹73 L	-₹36 L	-₹19 L	₹11 L	-₹1 Cr	-₹16 L	₹7 L	₹31 L	₹58 L
₹40,000	₹50,000	₹40,000	₹50,000	₹70,000	-₹23 L	₹11 L	₹14 L	₹0	₹0
-₹57 L	-₹85 L	-₹49 L	-₹31 L	-₹2 L	-₹1 Cr	-₹41 L	-₹19 L	₹31 L	₹58 L
-₹57 L	-₹30 L	-₹49 L	-₹31 L	-₹2 L	-₹1 Cr	-₹39 L	-₹25 L	₹25 L	₹49 L

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Unsecured Loans

Deferred Tax Assets / Liabilities

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2025
—
₹2 Cr
₹7 Cr
₹7 Cr
₹9 Cr
₹2 Cr
₹7 Cr
-₹92 L
₹6 Cr
—
₹62 L
₹1 Cr
₹19 L
₹74 L
₹3 Cr
₹19 Cr
₹7 Cr
—
₹21 Cr
₹9 Cr
₹12 Cr
₹2 Cr
₹2 Cr
₹3 Cr
₹15,000
₹17 Cr
—
₹2 Cr
₹42 L
-₹27 L
₹14,000
₹17 L
₹2 Cr
-₹64 L
₹19 Cr
₹47
₹47

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2025
-₹2 Cr
-₹9 L
₹1 Cr
-₹1 Cr
-₹1 Cr
-₹10 Cr
₹1 Cr
-₹9 Cr
₹9 Cr
-₹27 L

Fundamental Ratios

Consolidated

Standalone

No results found

Skybiotech Healthcare Share Price

118.15+1.15 (+0.98%)

-40.87% past 1 Year

Shareholding summary

Promoters

63.48%

FII

DII

Others

36.52%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
63.48%	63.48%	63.48%	63.48%	63.48%	63.48%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
36.52%	36.52%	36.52%	36.52%	36.52%	36.52%

Bulk & block deals

Name

Poonam Prakash Rathi

Dear Shares Private Limited

Sarthak Maheshwari

Poonam Prakash Rathi

Vijaykumar Mukhiya

Sushil Kumar Sharma

Prakashchandra Mohanlal Rathi

Subhmangal Merchandise Private Limited

Kellog Mercantile Privatelimited

Dinesh Kumar Choudhary

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
25 Mar 2025	Purchase	21.07 L	₹144.26	14.61 K	Bulk	0.762663	BSE
25 Mar 2025	Sell	21.07 L	₹144.26	14.61 K	Bulk	0.762663	BSE
27 Oct 2023	Sell	6.56 L	₹113.80	5.77 K	Bulk	0.301149	BSE
20 Mar 2023	Purchase	6.99 L	₹25.50	27.42 K	Bulk	1.431906	BSE
20 Mar 2023	Sell	3.31 L	₹25.50	13 K	Bulk	0.678851	BSE
20 Mar 2023	Sell	3.04 L	₹25.50	11.92 K	Bulk	0.622507	BSE
23 Feb 2022	Purchase	10.05 L	₹21.50	46.76 K	Bulk	2.441671	BSE
23 Feb 2022	Sell	3.93 L	₹21.50	18.30 K	Bulk	0.955614	BSE
23 Feb 2022	Sell	3.91 L	₹21.50	18.20 K	Bulk	0.950392	BSE
23 Feb 2022	Sell	1.75 L	₹21.51	8.14 K	Bulk	0.425222	BSE

Insider trading & SAST

Client name

Poonam Prakashchandra Rathi

Prakashchandra Rathi

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
21 Apr 2025	Promoter	Acquisition	0.76	13	—	14.61 K	25 Mar 2025	Market	2,49,087	SAST	29(2)	—
24 Mar 2023	Promoter	Acquisition	2.64	22.55	—	27.42 K	20 Mar 2023	Market	2,34,482	SAST	29(2)	—
28 Feb 2022	Promoter	Acquisition	0.48	35.08	—	5 K	24 Feb 2022	Market	3,64,888	SAST	29(2)	—
28 Feb 2022	Promoter	Acquisition	4.49	34.6	—	46.76 K	23 Feb 2022	Market	3,59,888	SAST	29(2)	—

Skybiotech Healthcare Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Skybiotech Healthcare Share Price

Skybiotech Healthcare Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Skybiotech Healthcare Share Price

Skybiotech Healthcare Share Price

Oscillators

Moving averages

Skybiotech Healthcare Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Skybiotech Healthcare Share Price

Corporate Actions

Company details

Skybiotech Healthcare Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Skybiotech Healthcare Share Price

News

Skybiotech Healthcar reports Profit after tax of 0.70 Lakhs, in the March 2026 quarter

Skybiotech Healthcare informs about disclosure

Skybiotech Healthcar reports Profit after tax of Rs -6.50 Lakhs, in the December 2025 quarter

Skybiotech Healthcare informs about board meeting

Skybiotech Healthcare Ltd Share Price Today

Skybiotech Healthcare Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator